BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fernández E, Toledo JR, Chiong M, Parra F, Rodríguez E, Montero C, Méndez L, Capucci L, Farnós O. Single dose adenovirus vectored vaccine induces a potent and long-lasting immune response against rabbit hemorrhagic disease virus after parenteral or mucosal administration. Vet Immunol Immunopathol 2011;142:179-88. [PMID: 21621855 DOI: 10.1016/j.vetimm.2011.05.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Cheng Y, Chen Z, Li C, Meng C, Wu R, Liu G. Protective immune responses in rabbits induced by a suicidal DNA vaccine of the VP60 gene of rabbit hemorrhagic disease virus. Antiviral Research 2013;97:227-31. [DOI: 10.1016/j.antiviral.2012.12.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
2 Wang L, Xia T, Guo T, Ru Y, Jiang Y, Cui W, Zhou H, Qiao X, Tang L, Xu Y, Li Y. Recombinant Lactobacillus casei Expressing Capsid Protein VP60 can Serve as Vaccine Against Rabbit Hemorrhagic Disease Virus in Rabbits. Vaccines (Basel) 2019;7:E172. [PMID: 31684059 DOI: 10.3390/vaccines7040172] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Müller C, Hrynkiewicz R, Bębnowska D, Maldonado J, Baratelli M, Köllner B, Niedźwiedzka-Rystwej P. Immunity against Lagovirus europaeus and the Impact of the Immunological Studies on Vaccination. Vaccines (Basel) 2021;9:255. [PMID: 33805607 DOI: 10.3390/vaccines9030255] [Reference Citation Analysis]
4 González Pose A, Montesino Seguí R, Maura Pérez R, Hugues Salazar F, Cabezas Ávila I, Altamirano Gómez C, Sánchez Ramos O, Roberto Toledo J. Characterisation of a New Molecule Based on Two E2 Sequences from Bovine Viral Diarrhoea-mucosal Disease Virus Fused To the Human Immunoglobulin Fc Fragment. J Vet Res 2021;65:27-37. [PMID: 33817392 DOI: 10.2478/jvetres-2021-0006] [Reference Citation Analysis]
5 Müller C, Ulrich R, Franzke K, Müller M, Köllner B. Crude extracts of recombinant baculovirus expressing rabbit hemorrhagic disease virus 2 VLPs from both insect and rabbit cells protect rabbits from rabbit hemorrhagic disease caused by RHDV2. Arch Virol 2019;164:137-48. [PMID: 30291504 DOI: 10.1007/s00705-018-4032-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
6 Farnós O, Venereo-Sánchez A, Xu X, Chan C, Dash S, Chaabane H, Sauvageau J, Brahimi F, Saragovi U, Leclerc D, Kamen AA. Rapid High-Yield Production of Functional SARS-CoV-2 Receptor Binding Domain by Viral and Non-Viral Transient Expression for Pre-Clinical Evaluation. Vaccines (Basel) 2020;8:E654. [PMID: 33158147 DOI: 10.3390/vaccines8040654] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
7 Jiang Q, Yu Z, Liu JS, Kong DS, Guo DC, Quan CS, Li BT, Hu XL, Qu L. Recombinant canine adenovirus type 2 expressing rabbit hemorrhagic disease virus VP60 protein provided protection against RHD in rabbits. Vet Microbiol 2018;213:15-20. [PMID: 29291998 DOI: 10.1016/j.vetmic.2017.11.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Zhang J, Jex E, Feng T, Sivko GS, Baillie LW, Goldman S, Van Kampen KR, Tang DC. An adenovirus-vectored nasal vaccine confers rapid and sustained protection against anthrax in a single-dose regimen. Clin Vaccine Immunol 2013;20:1-8. [PMID: 23100479 DOI: 10.1128/CVI.00280-12] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
9 Müller C, Ulrich R, Schinköthe J, Müller M, Köllner B. Characterization of protective humoral and cellular immune responses against RHDV2 induced by a new vaccine based on recombinant baculovirus. Vaccine 2019;37:4195-203. [PMID: 31182325 DOI: 10.1016/j.vaccine.2019.04.061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zhang J. Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines. Viruses 2012;4:2711-35. [PMID: 23202501 DOI: 10.3390/v4112711] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
11 Pose AG, Rodríguez ER, Piñeiro MJ, Montesino R, Sánchez O, Toledo JR. Quantitative ELISA sandwich for a new vaccine against avian influenza virus H5N1. J Immunol Methods 2018;459:70-5. [PMID: 29803776 DOI: 10.1016/j.jim.2018.05.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 Manish M, Verma S, Kandari D, Kulshreshtha P, Singh S, Bhatnagar R. Anthrax prevention through vaccine and post-exposure therapy. Expert Opinion on Biological Therapy 2020;20:1405-25. [DOI: 10.1080/14712598.2020.1801626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Fernández E, Toledo JR, Méndez L, González N, Parra F, Martín-Alonso JM, Limonta M, Sánchez K, Cabrales A, Estrada MP, Rodríguez-Mallón A, Farnós O. Conformational and thermal stability improvements for the large-scale production of yeast-derived rabbit hemorrhagic disease virus-like particles as multipurpose vaccine. PLoS One 2013;8:e56417. [PMID: 23460801 DOI: 10.1371/journal.pone.0056417] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
14 Sun Y, Yang Y, Zheng H, Xi D, Lin M, Zhang X, Yang L, Yan Y, Chu X, Bi B. Co-expression of Erns and E2 genes of classical swine fever virus by replication-defective recombinant adenovirus completely protects pigs against virulent challenge with classical swine fever virus. Res Vet Sci 2013;94:354-60. [PMID: 23092714 DOI: 10.1016/j.rvsc.2012.09.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
15 Fernández E, Toledo JR, Mansur M, Sánchez O, Gil DF, González-gonzález Y, Lamazares E, Fernández Y, Parra F, Farnós O. Secretion and assembly of calicivirus-like particles in high-cell-density yeast fermentations: strategies based on a recombinant non-specific BPTI-Kunitz-type protease inhibitor. Appl Microbiol Biotechnol 2015;99:3875-86. [DOI: 10.1007/s00253-014-6171-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
16 Gao J, Meng C, Chen Z, Li C, Liu G. Codon optimization of the rabbit hemorrhagic disease virus (RHDV) capsid gene leads to increased gene expression in Spodoptera frugiperda 9 (Sf9) cells. J Vet Sci 2013;14:441-7. [PMID: 23820215 DOI: 10.4142/jvs.2013.14.4.441] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
17 Rojas JM, Moreno H, García A, Ramírez JC, Sevilla N, Martín V. Two replication-defective adenoviral vaccine vectors for the induction of immune responses to PPRV. Vaccine 2014;32:393-400. [PMID: 24269622 DOI: 10.1016/j.vaccine.2013.11.033] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
18 Abrantes J, van der Loo W, Le Pendu J, Esteves PJ. Rabbit haemorrhagic disease (RHD) and rabbit haemorrhagic disease virus (RHDV): a review. Vet Res 2012;43:12. [PMID: 22325049 DOI: 10.1186/1297-9716-43-12] [Cited by in Crossref: 214] [Cited by in F6Publishing: 176] [Article Influence: 21.4] [Reference Citation Analysis]